• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Immunology

AstraZeneca is pleased to present healthcare professionals with a variety of immunology resources for your informational purposes. The educational materials are intended to provide information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

pipeline

November 10-15, 2023

American College Of Rheumatology Convergence 2023

Explore AstraZeneca Scientific Materials Visit website

May 31 - June 3, 2023

European Alliance of Associations for Rheumatology (EULAR) 2023

Explore AstraZeneca Scientific Materials Visit website

This page provides access to AstraZeneca presentations and posters shared during the congresses listed below. Content availability is subject to the timeliness and permissions outlined by respective congresses.

EULAR  2025

European Alliance of Associations for Rheumatology

 

June 11 - 14, 2025

Visit website

 

 

ACR 2024

American College of Rheumatology

 

November 14 - 19, 2024

Visit website

 

 

EULAR 2024

European Alliance Of Associations For Rheumatology

 

June 12 - 15, 2024

Visit website

 

 

  • SAPHNELO<sup>(TM)</sup> (anifrolumab-fnia) Injection
  • Eosinophilic Granulomatosis with Polyangiitis (EGPA) Explore Eosinophilic Granulomatosis with Polyangiitis (EGPA)
  • Systemic Lupus Erythematosus (SLE) Explore Systemic Lupus Erythematosus (SLE)

Email Recipient

  1. Colleague
  2. Myself

e-Learning

Biologic Therapies Summit X & Vasculitis 2023 Webcast

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

13-July-2023 to 13-July-2025

14 individual webcasts

Learn More

e-learning

Live 12th Annual Basic and Clinical Immunology for the Busy Clinician

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

19-Apr-2024 to 18-Apr-2026

This symposium will review recent immunologic advances to address knowledge gaps among busy clinicians regarding research in basic translational and clinical immunology. 

Learn More

e-learning

Web enduring 12th Annual Basic and Clinical Immunology for the Busy Clinician: Scientific Advances in Holistic and Integrative Care of Immune-Mediated Diseases

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

19-Apr-2024 to 18-Apr-2026

This symposium will review recent immunologic advances to address knowledge gaps among busy clinicians regarding research in basic translational and clinical immunology

Learn More

e-learning

Rheums for Improvement: Building Bridges in Evidenced-Based SLE Care | CASE DISCUSSION BROADCAST ONE

Iridium Continuing Education

16-Aug-2024 to 16-Aug-2025

30 Minute Case Discussion and  Monograph

Learn More

e-learning

Rheums for Improvement: Building Bridges in Evidenced-Based SLE Care | CASE DISCUSSION BROADCAST TWO

Iridium Continuing Education

23-Aug-2024 to 24-Aug-2025

30 Minute Case Discussion and  Monograph

Learn More

e-learning

Rheums for Improvement: Building Bridges in Evidenced-Based SLE Care | SOCIAL MEDIA FLASH TALK BROADCAST ONE

Iridium Continuing Education

13-Jun-2024 to 13-Jun-2025

15 Minute Social Media Broadcast

Learn More

e-learning

Rheums for Improvement: Building Bridges in Evidenced-Based SLE Care | SOCIAL MEDIA FLASH TALK BROADCAST TWO

Iridium Continuing Education

24-Jun-2024 to 24-Jun-2025

15 Minute Social Media Broadcast

Learn More

e-learning

Rheums for Improvement: Building Bridges in Evidenced-Based SLE Care | SOCIAL MEDIA FLASH TALK BROADCAST THREE

Iridium Continuing Education

25-Jun-2024 to 25-Jun-2025

15 Minute Social Media Broadcast

Learn More

e-learning

Rheums for Improvement: Building Bridges in Evidenced-Based SLE Care | SOCIAL MEDIA FLASH TALK BROADCAST FOUR

Iridium Continuing Education

26-Jun-2024 to 26-Jun-2025

15 Minute Social Media Broadcast

Learn More

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice